NIRI Elects Hulus Alpay New Board Chairman
The National Investor Relations Institute (NIRI) today announced the election of Hulus Alpay as the 2013 Chairman of the NIRI Board of Directors. Alpay is vice president, investor relations for Medidata Solutions, Inc. (Nasdaq: MDSO), a leading global provider of cloud-based clinical development solutions headquartered in New York City. He will succeed Derek Cole, vice president, investor relations and corporate communications, ARCA biopharma, Inc. at the NIRI Annual Meeting of members in late November.
“I am pleased that Hulus Alpay will be our 2013 NIRI Board Chairman,” said Jeffrey D. Morgan, president and chief executive officer of NIRI. “Hulus brings a tremendous depth of investor relations (IR) profession knowledge through his varied experiences as an IR products and services consultant, IR counselor and as a corporate IR professional. On behalf of the NIRI staff, board and membership, we look forward to having a board chair with such a comprehensive understanding of our profession, and we welcome him to his new role.”
Alpay said, “I am deeply honored to accept this important leadership role at an association that has been so vitally important not only to my own career but to countless others. Given the unique and valuable role of the investor relations professional, I look forward to helping our members successfully navigate change, drive awareness of the profession's importance in the modern corporation and in turn fuel their own professional success. Additional areas of focus during my tenure will include international membership growth, deepening the industry's knowledge around the continued evolution of the global capital markets and its impact on the U.S. IPO market, and most importantly, inspiring the best and brightest to look at the profession as an exciting area for professional growth and opportunity.” Alpay concluded, “I look forward to working with the highly talented staff, Board of Directors and the entire IR community to move OneNIRI, a strategic initiative that began several years ago for the benefit of all NIRI stakeholders, to the next level.”
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.